Overview

Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia

Status:
Active, not recruiting

Trial end date:
2019-12-01

Target enrollment:

Participant gender:

Summary

The investigators conducted a trial to determine whether methotrexate or methotrexate/dactinomycin single-course treatment work well as multiple courses of single methotrexate chemotherapy in low-risk gestational trophoblastic neoplasia. It is not yet known whether single-course of chemotherapy is as the same effectiveness as multicourse.

Phase:

Phase 3

Details

Lead Sponsor:

Ding Ma

Collaborators:

Huazhong University of Science and Technology
Shandong University
Zhejiang University

Treatments:

Dactinomycin
Methotrexate